About BONESUPPORT

The Challenge

• Bone is the second most transplanted tissue in the world, second only to blood. There are several methods to acquire bone tissue, the most common method is auto transplantation. The drawbacks with this procedure are that it requires two operational procedures and a general anesthesia. It involves the risk of infection and the post-operative phase might be very painful. Another disadvantage is that the amount of accessible bone tissue may not be sufficient in volume or quality for the procedure in question. Common alternatives to auto transplantation utilize bovine bone or human bone tissue banks.
• Osteoporosis is expected to grow explosively approximately every fourth man and almost every other woman over 50 is touched by the condition and the demographic shift will entail a dramatic rise in fragility fractures during the next decade. In the coming years in an ageing population every fourth European will be 70 or older. If osteoporosis sufferers are able to obtain the correct treatment their quality of life improves and society can curtail healthcare costs. BONESUPPORT™ offers technological leadership and innovative solutions.
• Research efforts have resulted in the patented technology of CERAMENT™ injectable bone substitute which carries a unique range of unique benefits and properties. The research team continues with cutting edge research to further develop and refine the present technology so that it can be used in other areas of medicine. To date the research has resulted in a number of publications in well respected scientific journals.